323 related articles for article (PubMed ID: 37335426)
1. Polymeric nanoparticles for DNA vaccine-based cancer immunotherapy: a review.
Danaeifar M; Negahdari B; Eslam HM; Zare H; Ghanaat M; Koushali SS; Malekshahi ZV
Biotechnol Lett; 2023 Sep; 45(9):1053-1072. PubMed ID: 37335426
[TBL] [Abstract][Full Text] [Related]
2. Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation.
Rahimian S; Fransen MF; Kleinovink JW; Christensen JR; Amidi M; Hennink WE; Ossendorp F
J Control Release; 2015 Apr; 203():16-22. PubMed ID: 25660830
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
[TBL] [Abstract][Full Text] [Related]
4. Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen.
Hashemi Goradel N; Nemati M; Bakhshandeh A; Arashkia A; Negahdari B
Int Immunopharmacol; 2023 Apr; 117():109887. PubMed ID: 36841155
[TBL] [Abstract][Full Text] [Related]
5. The quest for nanoparticle-powered vaccines in cancer immunotherapy.
Sun Z; Zhao H; Ma L; Shi Y; Ji M; Sun X; Ma D; Zhou W; Huang T; Zhang D
J Nanobiotechnology; 2024 Feb; 22(1):61. PubMed ID: 38355548
[TBL] [Abstract][Full Text] [Related]
6. Poly(lactic acid)-based particulate systems are promising tools for immune modulation.
Peres C; Matos AI; Conniot J; Sainz V; Zupančič E; Silva JM; Graça L; Sá Gaspar R; Préat V; Florindo HF
Acta Biomater; 2017 Jan; 48():41-57. PubMed ID: 27826003
[TBL] [Abstract][Full Text] [Related]
7. The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective.
Li Y; Ayala-Orozco C; Rauta PR; Krishnan S
Nanoscale; 2019 Oct; 11(37):17157-17178. PubMed ID: 31531445
[TBL] [Abstract][Full Text] [Related]
8. Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.
Bolhassani A; Javanzad S; Saleh T; Hashemi M; Aghasadeghi MR; Sadat SM
Hum Vaccin Immunother; 2014; 10(2):321-32. PubMed ID: 24128651
[TBL] [Abstract][Full Text] [Related]
9. Materials engineering strategies for cancer vaccine adjuvant development.
Zhang X; Yang B; Ni Q; Chen X
Chem Soc Rev; 2023 May; 52(9):2886-2910. PubMed ID: 37014050
[TBL] [Abstract][Full Text] [Related]
10. Hyperbranched Polymer-Based Vaccines for Cancer Immunotherapy.
Wang Z; Guo Y; Shen M; Wang Y; Shi X
Macromol Biosci; 2023 Nov; 23(11):e2300188. PubMed ID: 37300444
[TBL] [Abstract][Full Text] [Related]
11. Smart vaccine delivery based on microneedle arrays decorated with ultra-pH-responsive copolymers for cancer immunotherapy.
Duong HTT; Yin Y; Thambi T; Nguyen TL; Giang Phan VH; Lee MS; Lee JE; Kim J; Jeong JH; Lee DS
Biomaterials; 2018 Dec; 185():13-24. PubMed ID: 30216806
[TBL] [Abstract][Full Text] [Related]
12. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
Jin Z; Gao S; Cui X; Sun D; Zhao K
Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
[TBL] [Abstract][Full Text] [Related]
13. Mannan-decorated pathogen-like polymeric nanoparticles as nanovaccine carriers for eliciting superior anticancer immunity.
Xu Y; Ma S; Zhao J; Chen H; Si X; Huang Z; Yu Z; Song W; Tang Z; Chen X
Biomaterials; 2022 May; 284():121489. PubMed ID: 35364489
[TBL] [Abstract][Full Text] [Related]
14. Aliphatic Polyester-Based Materials for Enhanced Cancer Immunotherapy.
Chin AL; Wang X; Tong R
Macromol Biosci; 2021 Jul; 21(7):e2100087. PubMed ID: 33909344
[TBL] [Abstract][Full Text] [Related]
15. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
[No Abstract] [Full Text] [Related]
16. The future of cancer immunotherapy: DNA vaccines leading the way.
Pandya A; Shah Y; Kothari N; Postwala H; Shah A; Parekh P; Chorawala MR
Med Oncol; 2023 Jun; 40(7):200. PubMed ID: 37294501
[TBL] [Abstract][Full Text] [Related]
17. Gold nanoparticle mediated cancer immunotherapy.
Almeida JP; Figueroa ER; Drezek RA
Nanomedicine; 2014 Apr; 10(3):503-14. PubMed ID: 24103304
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches.
Davodabadi F; Sarhadi M; Arabpour J; Sargazi S; Rahdar A; Díez-Pascual AM
J Control Release; 2022 Sep; 349():844-875. PubMed ID: 35908621
[TBL] [Abstract][Full Text] [Related]
19. Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses.
Yin Q; Wang Y; Xiang Y; Xu F
Hum Vaccin Immunother; 2022 Nov; 18(6):2119020. PubMed ID: 36170662
[TBL] [Abstract][Full Text] [Related]
20. Stimuli-Responsive Polymeric Nanovaccines Toward Next-Generation Immunotherapy.
Mao L; Ma P; Luo X; Cheng H; Wang Z; Ye E; Loh XJ; Wu YL; Li Z
ACS Nano; 2023 Jun; 17(11):9826-9849. PubMed ID: 37207347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
